Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Equivalence of mometasone cream and Elomet cream in eczema
TCTR20220210004Phase 3Enrolling by invitation
- Sponsor
- Zuellig Pharma
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of LAS 41002, mometasone in atopic dermatitis (AD), sponsored by Zuellig Pharma. Started Feb 2022; status: enrolling by invitation.
02
Drugs
LAS 41002mometasone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on TCTR20220210004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220210004.